AXL and neoplasm: Given that intra-tumoral Tyro3, Mer, and Axl signaling contributes to tumor growth, immune evasion, drug resistance, proliferation, and metastasis [177,178,179], TAM RTKs represent an important drug candidate to simultaneously target both malignant cells and immune cells in order to enhance anti-tumor immunity.